17.67
price up icon2.24%   0.37
 
loading
Precedente Chiudi:
$17.30
Aprire:
$17.75
Volume 24 ore:
317.37K
Relative Volume:
0.28
Capitalizzazione di mercato:
$1.26B
Reddito:
$133.62M
Utile/perdita netta:
$-177.37M
Rapporto P/E:
-6.1142
EPS:
-2.89
Flusso di cassa netto:
$23.50M
1 W Prestazione:
+7.14%
1M Prestazione:
+27.25%
6M Prestazione:
+83.30%
1 anno Prestazione:
-30.20%
Intervallo 1D:
Value
$17.44
$18.30
Intervallo di 1 settimana:
Value
$15.69
$18.69
Portata 52W:
Value
$6.92
$26.59

Xencor Inc Stock (XNCR) Company Profile

Name
Nome
Xencor Inc
Name
Telefono
626-305-5900
Name
Indirizzo
465 N. HALSTEAD ST., PASADENA, CA
Name
Dipendente
250
Name
Cinguettio
Name
Prossima data di guadagno
2025-08-01
Name
Ultimi documenti SEC
Name
XNCR's Discussions on Twitter

Confronta XNCR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
XNCR
Xencor Inc
17.70 1.24B 133.62M -177.37M 23.50M -2.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.18 115.56B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
706.98 75.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
431.60 60.52B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
908.12 55.48B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
198.55 43.51B 447.02M -1.18B -906.14M -6.1812

Xencor Inc Stock (XNCR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-11-24 Iniziato Truist Buy
2025-10-29 Aggiornamento Barclays Underweight → Overweight
2025-09-17 Ripresa Barclays Underweight
2025-09-03 Downgrade BofA Securities Buy → Neutral
2025-04-21 Iniziato William Blair Outperform
2024-12-12 Iniziato Wells Fargo Overweight
2024-12-02 Aggiornamento Piper Sandler Neutral → Overweight
2024-04-16 Reiterato BTIG Research Buy
2024-02-28 Downgrade Piper Sandler Overweight → Neutral
2023-05-19 Iniziato BofA Securities Buy
2022-12-06 Iniziato Cowen Outperform
2022-10-13 Aggiornamento Raymond James Outperform → Strong Buy
2022-09-21 Iniziato JP Morgan Overweight
2022-07-06 Ripresa Canaccord Genuity Buy
2022-02-11 Iniziato BMO Capital Markets Outperform
2022-01-21 Iniziato SMBC Nikko Outperform
2021-12-15 Iniziato H.C. Wainwright Buy
2021-10-15 Ripresa BTIG Research Buy
2021-02-24 Aggiornamento Raymond James Mkt Perform → Outperform
2020-03-04 Iniziato Barclays Underweight
2020-02-25 Aggiornamento Guggenheim Neutral → Buy
2020-01-30 Iniziato RBC Capital Mkts Outperform
2019-11-20 Ripresa Guggenheim Neutral
2019-08-07 Downgrade Guggenheim Buy → Neutral
2019-08-07 Downgrade Raymond James Outperform → Mkt Perform
2019-06-13 Iniziato Mizuho Buy
2019-04-12 Iniziato Guggenheim Buy
2019-03-27 Iniziato Berenberg Buy
2019-03-15 Iniziato Raymond James Outperform
2018-09-10 Ripresa BTIG Research Buy
2018-03-28 Ripresa Leerink Partners Outperform
2017-03-02 Iniziato Instinet Neutral
2017-03-02 Reiterato Wedbush Outperform
2016-10-04 Iniziato Piper Jaffray Overweight
2015-12-22 Iniziato Canaccord Genuity Buy
2015-08-05 Reiterato MLV & Co Buy
2015-02-12 Reiterato Oppenheimer Outperform
2015-01-28 Reiterato MLV & Co Buy
2014-07-11 Iniziato Oppenheimer Outperform
Mostra tutto

Xencor Inc Borsa (XNCR) Ultime notizie

pulisher
Dec 06, 2025

Pullback Watch: What momentum indicators show for Xencor Inc stock2025 Sector Review & Smart Swing Trading Alerts - BỘ NỘI VỤ

Dec 06, 2025
pulisher
Dec 06, 2025

Is Xencor Stock Built to Withstand a Pullback? - Trefis

Dec 06, 2025
pulisher
Dec 05, 2025

How Xencor Inc. stock performs in interest rate cycles2025 Geopolitical Influence & Detailed Earnings Play Alerts - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Xencor, Inc. $XNCR Shares Acquired by Panagora Asset Management Inc. - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

What hedge fund moves indicate for Xencor Inc. (XE9) stockWeekly Earnings Recap & Low Drawdown Investment Strategies - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

What momentum indicators show for Xencor Inc. stock2025 Price Action Summary & High Conviction Investment Ideas - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Is Xencor Inc. stock a defensive play in 2025Quarterly Profit Review & Daily Growth Stock Investment Tips - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Xencor (XNCR) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 02, 2025
pulisher
Dec 02, 2025

Xencor Inc. diskutieren - sharewise.com

Dec 02, 2025
pulisher
Nov 30, 2025

How supply shortages influence Xencor Inc. (XE9) stockJuly 2025 Opening Moves & Safe Capital Investment Plans - BỘ NỘI VỤ

Nov 30, 2025
pulisher
Nov 30, 2025

Xencor, Inc. (XNCR) Stock Forecasts - Yahoo Finance

Nov 30, 2025
pulisher
Nov 30, 2025

Xencor, Inc. (NASDAQ:XNCR) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Nov 30, 2025
pulisher
Nov 27, 2025

Rhenman & Partners Asset Management AB Has $1.30 Million Stake in Xencor, Inc. $XNCR - MarketBeat

Nov 27, 2025
pulisher
Nov 27, 2025

Will Xencor Inc. (XE9) stock remain on Wall Street radarJuly 2025 Sector Moves & Real-Time Volume Triggers - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 26, 2025

Truist Financial Initiates a Buy Rating on Xencor (XNCR) - The Globe and Mail

Nov 26, 2025
pulisher
Nov 25, 2025

Xencor (NASDAQ:XNCR) Coverage Initiated by Analysts at Truist Financial - MarketBeat

Nov 25, 2025
pulisher
Nov 25, 2025

There's No Escaping Xencor, Inc.'s (NASDAQ:XNCR) Muted Revenues Despite A 27% Share Price Rise - simplywall.st

Nov 25, 2025
pulisher
Nov 25, 2025

DCF Advisers LLC Cuts Stake in Xencor, Inc. $XNCR - MarketBeat

Nov 25, 2025
pulisher
Nov 25, 2025

Xencor Shares Surge on Clinical Breakthroughs and Analyst Confidence - Ad-hoc-news.de

Nov 25, 2025
pulisher
Nov 24, 2025

Truist Securities Initiates Coverage of Xencor (XNCR) with Buy Recommendation - MSN

Nov 24, 2025
pulisher
Nov 24, 2025

Truist Securities initiates coverage on Xencor stock with Buy rating By Investing.com - Investing.com Canada

Nov 24, 2025
pulisher
Nov 24, 2025

Truist Securities Initiates Coverage on Xencor (XNCR) with Buy R - GuruFocus

Nov 24, 2025
pulisher
Nov 24, 2025

Truist Securities initiates coverage on Xencor stock with Buy rating - Investing.com India

Nov 24, 2025
pulisher
Nov 23, 2025

Xencor’s XmAb819 Study: A Promising Step in Cancer Treatment - MSN

Nov 23, 2025
pulisher
Nov 21, 2025

Primecap Management Co. CA Has $82.75 Million Holdings in Xencor, Inc. $XNCR - MarketBeat

Nov 21, 2025
pulisher
Nov 21, 2025

Is Xencor Inc. stock a safe buy before earningsJuly 2025 Reactions & Free High Accuracy Swing Entry Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will Xencor Inc. (XE9) stock benefit from commodity supercycleJuly 2025 Outlook & Weekly Setup with High ROI Potential - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Xencor Shares Show Renewed Promise as Biotech Specialist Stages Recovery - Ad-hoc-news.de

Nov 21, 2025
pulisher
Nov 21, 2025

Bank of Montreal Can Boosts Holdings in Xencor, Inc. $XNCR - MarketBeat

Nov 21, 2025
pulisher
Nov 21, 2025

Xencor Inc (XE9.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada

Nov 21, 2025
pulisher
Nov 20, 2025

Is Xencor Inc. (XE9) stock undervalued by metricsWeekly Loss Report & Free Long-Term Investment Growth Plans - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Xencor upgraded to Overweight from Underweight at Barclays - MSN

Nov 20, 2025
pulisher
Nov 20, 2025

Will Xencor Inc. (XE9) stock hit Wall Street targetsWatch List & Long Hold Capital Preservation Plans - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Is Xencor Inc. (XE9) stock undervalued historically2025 Volatility Report & Real-Time Market Trend Scan - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why analysts remain bullish on Xencor Inc. stockChart Signals & Long-Term Investment Growth Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Xencor Inc. stock attractive for growth ETFs2025 Top Decliners & Community Consensus Trade Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Should you hold or exit Xencor Inc. now2025 Breakouts & Breakdowns & Precise Buy Zone Tips - newser.com

Nov 19, 2025

Xencor Inc Azioni (XNCR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$38.98
price down icon 1.87%
$98.58
price down icon 3.96%
$31.82
price up icon 0.22%
$97.63
price up icon 1.43%
biotechnology ONC
$325.77
price up icon 0.98%
$199.29
price down icon 2.33%
Capitalizzazione:     |  Volume (24 ore):